Browse by Medical Category
Christopher McDougle, MD, is the Director of the Lurie Center for Autism, a multidisciplinary program that treats children, adolescents and adults with autism spectrum and other neurodevelopmental disorders. In addition to persons with autism spectrum disorder, Dr. McDougle specializes in the diagnosis and pharmacological treatment of those with Williams syndrome, Down syndrome, Fragile X syndrome, and Angelman syndrome, among others, especially adults.
Go To Programs
MassGeneral Hospital for Children
Go To Specialties
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Christopher McDougle, MD, received a B.A. in Chemistry from Valparaiso University in 1981 (with Highest Distinction) and an M.D. from Indiana University School of Medicine in 1986 (with Highest Distinction). He subsequently completed a residency in psychiatry at Yale University School of Medicine (1990) and a fellowship in child and adolescent psychiatry at the Yale Child Study Center (1995). After seven years on the faculty at Yale, Dr. McDougle joined the Indiana University School of Medicine (IUSM) in 1997 as the Raymond E. Houk Professor of Psychiatry and Director of the Section of Child and Adolescent Psychiatry. In September of 2000, Dr. McDougle was named the Albert Eugene Sterne Professor of Psychiatry and Chairman of the Department of Psychiatry at the IUSM. He continued on as Director of the Section of Child and Adolescent Psychiatry, as well. In the fall of 2011, Dr. McDougle became the Director of the Lurie Center for Autism and the Nancy Lurie Marks Professor in the Field of Autism at Harvard Medical School.
Dr. McDougle was elected to the American College of Neuropsychopharmacology in 1995, and is now a fellow. He was twice chosen as Teacher of the Year by the Yale Psychiatry Residents. In 2002, Dr. McDougle was selected as a recipient of the 12th Annual Nancy C.A. Roeske, M.D. Certificate of Recognition for Excellence in Medical Student Education from the American Psychiatric Association, and in 2007 he was selected as a recipient of the Annual Irma Bland Award for Excellence in Teaching Residents, also by the American Psychiatric Association. Dr. McDougle was awarded the Frank J. Menolascino Award from the American Psychiatric Association in 2009 and the George Tarjan Award from the American Academy of Child and Adolescent Psychiatry in 2012. In 2003, he was appointed Associate Editor of the Journal of Autism and Developmental Disorders.
Dr. McDougle is an internationally-recognized expert in the neurobiology and neuropsychopharmacology of childhood-onset neuropsychiatric disorders including autistic disorder. His research interests also include the etiology and pathophysiology of mental retardation syndromes.
Dr. McDougle has been awarded two Young Investigator Awards from the National Alliance for Research on Schizophrenia and Depression (NARSAD), an Independent Investigator Award from NARSAD, a grant from the Theodore and Vada Stanley Research Foundation, a Research Unit on Pediatric Psychopharmacology (RUPP) contract, a RUPP-Psychosocial Intervention (PI) grant, an Autism Centers of Excellence (ACE) Network grant from NICHD and additional research grants from the National Institutes of Health for the study of autism and related pervasive developmental disorders.
View my most recent publications at PubMed
The Lurie Center for Autism receives two gifts of $5 million to support research and operations.
In General awards and honors
The George Tarjan Award recognizes a child and adolescent psychiatrist who has made significant contributions in a lifetime career or single seminal work to the understanding or care of those with developmental disabilities. These contributions must have national and/or international stature and clearly demonstrate lasting effects.
Dr. McDougle is listed among the top 1% of doctors in the nation in the specialty of child and adolescent psychiatry.
The Lurie Center for Autism at MassGeneral Hospital for Children will take part in a $12.6 million study of the effectiveness of using intranasal oxytocin – a hormone believed to be important in the formation of social bonds – to treat impaired social relatedness in children and teens with autism spectrum disorders.
The Lurie Center for Autism will take part in the largest study ever done on a medication to treat impaired social relatedness in children and teenagers with autism spectrum disorders.
Congratulations to Chris McDougle, MD, the first incumbent of the Nancy Lurie Marks Professorship in the Field of Autism at Harvard Medical School.
MGH leaders in autism care and research gathered Nov. 29 at the Liberty Hotel to welcome Christopher J. McDougle, MD, as the new director of the Lurie Center for Autism.
Dr. Christopher McDougle, the director of the Lurie Center for Autism, talks about his work as a psychiatrist.
Back to Top